Unlike the adaptive immune response, the innate response acts quickly and is considered the first line of defense against pathogens and foreign DNA, such as tumor cells. To be effective, the innate immune response relies on several cell types and a multitude of proteins such as interferons (INFs), which typically fight microbial infection-causing pathogens. Fighting unwanted microbes is essential, but dysregulation of the innate immune system leads to many inflammatory and autoimmune disorders. BellBrook Labs is leveraging its Transcreener technology to build enabling products and services focusing on targets found to help regulate innate immunity. Our goal is to help accelerate the discovery of potential treatments for autoimmune disease and cancer.